Company Rasna Therapeutics, Inc. Other OTC
Equities
RASP
US7538881068
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Keeren Shah
DFI | Director of Finance/CFO | 47 | 16-06-30 |
Jules S. Jacob
PRN | Corporate Officer/Principal | - | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 16-07-31 |
Willy Simon
CHM | Chairman | 72 | 20-10-13 |
Gary Jacob
BRD | Director/Board Member | 77 | 20-12-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 771,811,360 | 114,303,692 ( 14.81 %) | 0 | 14.81 % |
Company contact information
![address Rasna Therapeutics, Inc.(RASP)](https://cdn.zonebourse.com/static/address/31472023.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.12% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-15.78% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |